ADMA Biologics, Inc. (ADMA)
9.19
+0.08
(+0.88%)
USD |
NASDAQ |
Apr 02, 16:00
9.20
+0.01
(+0.11%)
After-Hours: 20:00
ADMA Biologics Market Cap : 2.210B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.997B |
| Inovio Pharmaceuticals, Inc. | 50.48M |
| ANI Pharmaceuticals, Inc. | 1.626B |
| AtriCure, Inc. | 1.486B |
| Ligand Pharmaceuticals, Inc. | 3.987B |
Market Cap Related Metrics
| PE Ratio | 15.34 |
| PS Ratio | 4.421 |
| Price to Book Value | 4.585 |
| Price to Free Cash Flow | 82.01 |
| Price | 9.19 |
| Earnings Yield | 6.52% |
| Operating PE Ratio | 11.78 |
| Normalized PE Ratio | 15.10 |